|
Volumn 13, Issue 12, 2002, Pages 1113-1121
|
In vivo half life of nanoencapsulated L-asparaginase
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BLOOD;
ENZYMES;
MODIFICATION;
ORGANIC COMPOUNDS;
PH EFFECTS;
RADIOACTIVITY;
TOXICITY;
WATER;
HALF LIFE;
NANOSTRUCTURED MATERIALS;
ASPARAGINASE;
HEPARIN;
MACROGOL;
NANOPARTICLE;
POLY(3 HYDROXYBUTYRATE CO 3 HYDROXYVALERATE);
POLY(3 HYDROXYBUTYRIC ACID);
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ANTIGENICITY;
BIODEGRADABILITY;
CHEMICAL MODIFICATION;
CONFERENCE PAPER;
CONTROLLED STUDY;
DRUG ACTIVITY;
DRUG CONJUGATION;
DRUG CYTOTOXICITY;
DRUG FORMULATION;
DRUG HALF LIFE;
ENCAPSULATION;
ENZYME ACTIVITY;
ENZYME DENATURATION;
IMMUNOGENICITY;
IN VIVO STUDY;
ISOELECTRIC POINT;
ISOTOPE LABELING;
MOUSE;
NONHUMAN;
PH MEASUREMENT;
PHASE TRANSITION;
PRIORITY JOURNAL;
RADIOACTIVITY;
TIME SERIES ANALYSIS;
|
EID: 0036973847
PISSN: 09574530
EISSN: None
Source Type: Journal
DOI: 10.1023/A:1021125617828 Document Type: Conference Paper |
Times cited : (64)
|
References (40)
|